Fiduciary Trust Co Decreases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Fiduciary Trust Co lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,915 shares of the financial services provider’s stock after selling 121 shares during the quarter. Fiduciary Trust Co’s holdings in iShares Biotechnology ETF were worth $1,007,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $29,000. Highline Wealth Partners LLC bought a new stake in iShares Biotechnology ETF during the third quarter valued at approximately $30,000. Bbjs Financial Advisors LLC purchased a new stake in iShares Biotechnology ETF during the second quarter valued at approximately $31,000. Ashton Thomas Securities LLC purchased a new stake in iShares Biotechnology ETF during the third quarter valued at approximately $36,000. Finally, Voisard Asset Management Group Inc. purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $59,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $141.55 on Friday. iShares Biotechnology ETF has a 1 year low of $119.95 and a 1 year high of $150.57. The firm has a fifty day moving average price of $142.84 and a 200-day moving average price of $141.96.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.